Developer docs
API playgroundTry for free, no card

Search company profiles

OpenCures

Full company profile

uuid000cq2w

Namestring
OpenCures
Legal namestring
OpenOme Inc.
Websiteurl
opencures.org
Company typeenum
Private
Founded yearint
2018
Descriptiontext

OpenCures (legally OpenOme Inc. DBA OpenCures) is a hybrid for-benefit biotechnology enterprise founded in 2018 by Kevin Perrott, PhD, and headquartered in Novato, California. The company operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, self-tracking inputs, and biobanked biospecimens into a unified personal health management system, paired with an exclusive arrangement to distribute Prodrome Sciences' research-grade metabolomics blood assay (ProdromeScan). It serves three primary segments: proactive individuals and biohackers seeking research-grade biomarker insights, longevity and functional medicine clinics using its client management SaaS, and research organizations running remote decentralized trials through its trial management module. A 501c(3) nonprofit partner (OpenCures Access) was established alongside the for-benefit entity to pursue mission-aligned research activities not directly profitable.

The platform's technical architecture centers on multiomic data categorization against reference databases, automated biomarker analytics with personalized functional ranges (including derived scores such as BMI, PhenoAge, and Framingham Risk Score), correlation and baseline detection on longitudinal inputs, AI-assisted supplement protocol planning, and a generic CSV/PDF data import engine. Complementary services include biobanking (subscription), blood draw logistics at the Novato office and via mobile phlebotomy (~$120 per session) nationwide in the US, and white-label platform deployment for partner clinics and laboratories. Compliance posture includes HIPAA Safe Harbor de-identification and self-attested GDPR handling, with data encrypted at rest for personally identifiable reports.

Revenue is generated through four streams: freemium-to-paid individual subscriptions with upsell to assays and biobanking; unit-priced research-grade assay sales with pay-as-you-go phlebotomy; annual tiered B2B SaaS subscriptions for longevity clinics; and enterprise subscriptions for research organizations plus white-label licensing fees. Distribution is predominantly direct-to-consumer through opencures.org and shop.opencures.org, with direct sales to mid-market clinics and research organizations and community-led referrals through longevity and biohacker networks. Named relationships include LongeCity (citizen science nonprofit), longevity clinics using the professional SaaS, research organizations running trials, and a coalition partnership within the Stanford-led THRIVE initiative backed by ARPA-H ($34.5M total program funding). The platform reports a 4.8/5 Trustpilot rating from over 2,000 reviews.

Short descriptiontext

OpenCures operates a cloud-based platform that aggregates biomarker, wearable, and self-tracking data for proactive individuals, longevity clinics, and research organizations, paired with an exclusive metabolomics assay (ProdromeScan), biobanking services, and a 501c(3) nonprofit partner.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNovato, United States
HQ citystring
Novato
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health data platform, biomarker tracking, longevity research, biobanking services, clinical trial management
Industry4 codes
PRIMARYHLACAIAL
Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAOAE
eConsent & Digital Identity for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAJAJ
Governance, Risk & Compliance (GRC) + HIPAA/HITRUST/ISO Readiness
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Cybersecurity, Identity & Privacy
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Longevity Health Data Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Platform SaaS Subscriptions
TypeSubscription Recurring
Description

The for-benefit entity offers cloud-based software subscriptions to health professionals (longevity clinic client management) and research organizations (trial management). These are recurring revenue subscriptions with tiered feature access.

opencures.org
2ProdromeScan & Assay Services
TypeOne Time License
Description

OpenCures offers the ProdromeScan blood assay (metabolomics-based) and other blood panel tests directly to self-directed researchers and consumers. This is a one-time per-order revenue stream. Optional mobile phlebotomy service at ~$120 is available.

opencures.org
3Biobanking Services
TypeSubscription Recurring
Description

Biospecimen storage service where participants can biobank remaining blood samples for future assay use, with ownership and access control retained by the individual. Revenue is generated per sample stored.

opencures.org
4White-label & Licensed Platform
TypeLicensing Royalties
Description

OpenCures offers white-label versions of its platform to other longevity clinics, laboratories, and research organizations, embedding its technology into partner operations for a licensing fee.

opencures.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1ProdromeScan assay — research-grade metabolomics blood test with results and interpretation workshop
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Price not publicly disclosed on the website; available to order through shop.opencures.org or by direct contact. Includes a workshop for interpreting results.

opencures.org
2Mobile phlebotomy add-on for remote blood draws
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Approximately $120 per blood draw session in addition to assay costs.

opencures.org
3Platform for Individuals — personal health management dashboard with data integration and analytics
ModelFreemiumBilling cadenceMonthly
Notes

Free tier available for basic access; premium features for advanced analytics and guided services.

opencures.org
4Platform for Professionals — SaaS client management for longevity clinics
ModelSubscriptionBilling cadenceAnnual
Notes

Cloud-based subscription for health professionals; tiered plans with automations and integrations. 4.8/5 on Trustpilot based on 2000+ reviews.

opencures.org
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

OpenCures operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, and self-tracking inputs into a unified personal health management system. The company sells the research-grade ProdromeScan metabolomics blood assay, biobanking storage services, and dedicated SaaS modules for longevity clinics (client management) and research organizations (decentralized trial management). A hybrid for-benefit legal structure pairs the commercial entity (OpenOme Inc., DBA OpenCures) with a 501(c)(3) charity (OpenCures Access) to accelerate health technology development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Platform rated 4.8/5 on Trustpilot based on 2000+ reviews
+1 more record
Product overview1 text field

OpenCures operates as a hybrid for-benefit enterprise offering a multi-product ecosystem centered on the OpenCures Platform (my.opencures.org), a web-based health data management system. The platform enables individuals to track biomarkers, integrate lab results and wearable data, and analyze health correlations. Complementary services include the ProdromeScan metabolomic assay (offered exclusively through OpenCures), biobanking for biospecimen storage, blood draw services (in-office and mobile phlebotomy), and dedicated modules for health professionals (client management) and researchers (trial management). An AI-assisted supplement planning feature personalizes wellness recommendations based on aggregated health data.

Product and service7 records
1OpenCures Platform
CategoryCore Platform
Description

A web-based health management platform at my.opencures.org that enables individuals to track health metrics, integrate lab results and wearable data, analyze longitudinal correlations, and participate in self-directed research with automated biomarker calculations.

2ProdromeScan
CategoryAssay Service
Description

A research-grade metabolomic blood test offered exclusively through OpenCures to self-directed researchers and consumers, providing comprehensive biomarker analysis with results automatically imported into the OpenCures Platform and accompanied by an interpretation workshop.

3Biobanking Service
CategoryStorage Service
Description

Frozen biospecimen storage service for blood samples with user-controlled ownership and access, enabling future testing as new assays or biological age clocks become available.

4Platform for Professionals
CategoryProfessional SaaS
Description

A cloud-based client management system designed for longevity clinics, providing automated workflows, multi-source health data ingestion, automated reporting, and systematic holistic care delivery for client practices.

5Trial Management Platform
CategoryResearch SaaS
Description

A research platform enabling decentralized trial management with media-rich study landing pages, protocol builders, guided participant flows, automated notifications, consent collection, questionnaires, multi-source data collection, and access to biobanking and assays.

6Blood Draw Services
CategoryPhlebotomy Service
Description

Venous blood collection services available at the Novato, CA headquarters or via mobile phlebotomy (approximately $120 per session) nationwide in the US, required to obtain samples for the ProdromeScan assay and other tests.

7White-label Platform Licensing
CategoryLicensed Platform
Description

White-label deployments of the OpenCures platform offered to partner longevity clinics, laboratories, and research organizations, embedding the technology into partner operations for a licensing fee.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

WHOOP joined the $34.5 million ARPA-H-backed THRIVE initiative led by Stanford, with OpenCures as a named coalition partner. WHOOP will contribute continuous physiological data from its wearable devices to the PROSPR IC score model, integrating with OpenCures' data infrastructure and research participant network. The coalition aims to develop an FDA-grade Intrinsic Capacity score predicting major health outcomes up to 20 years in advance.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

Stanford's PROSPR (Population-based Imaging and Informatics) team leads the THRIVE initiative, developing the PROSPR Intrinsic Capacity (IC) score model. OpenCures participates as a data and platform partner in the coalition, contributing participant engagement and multiomic data aggregation capabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

The Buck Institute for Research on Aging is a coalition partner in the Stanford-led THRIVE initiative. OpenCures participates alongside the Buck Institute to contribute to the development of the IC score and translate it into accessible at-home assessments.

4Methuselah Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

Methuselah Foundation is a coalition partner in the ARPA-H-backed THRIVE initiative alongside OpenCures. The foundation has a long history supporting longevity science and is collaborating to accelerate translation of aging research into accessible health assessments.

longevity.technology
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

YMCA is a coalition partner in the Stanford-led THRIVE initiative. As a community organization with broad reach, YMCA contributes to the accessibility and translation of the IC score into community settings.

Strategic tierCoreTypeTechnology or Integration
Description

OpenCures has an exclusive arrangement with ProdromeSciences to provide the ProdromeScan (research-grade metabolomics blood assay) to self-directed researchers. ProdromeSciences performs the analysis in San Diego, and OpenCures handles participant engagement, blood draw logistics, and result interpretation support.

7LongeCity
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LongeCity collaborated with OpenCures to create a platform for the longevity community to share and analyze biomarker data. LongeCity's community of citizen scientists uses OpenCures' platform features for data management and research collaboration.

opencures.org
8Open Longevity
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Open Longevity is listed as a partner organization on OpenCures' About page, collaborating within the integrated network of longevity clinics, research organizations, and biohacker communities.

opencures.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AgelessRX is listed as a partner organization, collaborating with OpenCures within the longevity ecosystem to accelerate access to health technologies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rejuve.io is listed as a partner on OpenCures' About page, contributing to the integrated network approach to longevity research and health technology development.

11OpenCures Access (501c3)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

OpenCures partners with OpenCures Access, a 501c(3) nonprofit charity, to implement a multipronged strategy for accelerating health technology development. The nonprofit handles tasks that may not be directly profitable but are crucial for R&D, while the for-benefit entity handles commercially viable operations.

opencures.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct-to-consumer blood-testing platform offering 100+ biomarker panels with longitudinal tracking and clinician review. Highly comparable to OpenCures' ProdromeScan + OpenCures Platform stack, targeting the same self-directed biohacker/health-conscious consumer.

TypeDirect peer
Description

Biomarker analysis platform that ingests blood, wearable, and DNA data and produces personalized health recommendations. Closely matches OpenCures' biomarker analytics, personalized functional ranges, and AI-assisted supplement planning capabilities.

TypeDirect peer
Description

Consumer gut-microbiome and transcriptomic testing with AI-driven personalized nutrition recommendations. Same DTC-plus-data-platform-plus-AI-supplement model as OpenCures, and a direct competitor for self-directed longevity and wellness share of wallet.

TypeDirect peer
Description

Biological-age testing and longevity-focused supplement regimens sold direct-to-consumer with longitudinal self-tracking. Targets the same longevity-conscious biohacker segment and operates with a similar precision-prevention positioning.

TypeDirect peer
Description

Longevity biotechnology company offering consumer-grade epigenetic biomarker products (e.g., Index) and supplements. Comparable in the consumer-longevity data + intervention offering that OpenCures is assembling through ProdromeScan and the platform.

TypeDirect peer
Description

Continuous metabolic monitoring (CGM) software with biomarker aggregation and AI-driven recommendations. Comparable consumer health-data SaaS playbook, sharing OpenCures' emphasis on longitudinal data, integrations, and AI-assisted intervention planning.

TypeBroad incumbent
Description

Large supplement and health-testing brand with consumer lab-test offerings and practitioner channel. Overlaps with OpenCures' supplement-planning and biomarker analytics but operates at scale across multiple verticals rather than focusing on the longevity-research niche.

TypeBroad incumbent
Description

Premium longevity concierge-medicine and whole-genome/imaging diagnostic platform. Pursues a similar 'proactive longevity data' thesis but at a high-touch clinic + diagnostics model rather than OpenCures' DTC + community-driven model.

TypeBroad incumbent
Description

Network of longevity/preventive-medicine clinics offering advanced diagnostics and AI-driven insights. Overlaps with OpenCures' longevity-clinic professional platform as both serve the same health-professional buyer with data-driven practice infrastructure.

TypeEmerging player
Description

Early-stage longevity-focused biomarker tracking and health-coaching platform. Targeting a similar self-directed health-optimization audience with a smaller subscription-based offering, representing a possible fast-moving entrant in OpenCures' core segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OpenCures

Longevity Health Data Platformopencures.org

OpenCures operates a cloud-based platform that aggregates biomarker, wearable, and self-tracking data for proactive individuals, longevity clinics, and research organizations, paired with an exclusive metabolomics assay (ProdromeScan), biobanking services, and a 501c(3) nonprofit partner.

What OpenCures does

OpenCures (legally OpenOme Inc. DBA OpenCures) is a hybrid for-benefit biotechnology enterprise founded in 2018 by Kevin Perrott, PhD, and headquartered in Novato, California. The company operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, self-tracking inputs, and biobanked biospecimens into a unified personal health management system, paired with an exclusive arrangement to distribute Prodrome Sciences' research-grade metabolomics blood assay (ProdromeScan). It serves three primary segments: proactive individuals and biohackers seeking research-grade biomarker insights, longevity and functional medicine clinics using its client management SaaS, and research organizations running remote decentralized trials through its trial management module. A 501c(3) nonprofit partner (OpenCures Access) was established alongside the for-benefit entity to pursue mission-aligned research activities not directly profitable.

The platform's technical architecture centers on multiomic data categorization against reference databases, automated biomarker analytics with personalized functional ranges (including derived scores such as BMI, PhenoAge, and Framingham Risk Score), correlation and baseline detection on longitudinal inputs, AI-assisted supplement protocol planning, and a generic CSV/PDF data import engine. Complementary services include biobanking (subscription), blood draw logistics at the Novato office and via mobile phlebotomy (~$120 per session) nationwide in the US, and white-label platform deployment for partner clinics and laboratories. Compliance posture includes HIPAA Safe Harbor de-identification and self-attested GDPR handling, with data encrypted at rest for personally identifiable reports.

Revenue is generated through four streams: freemium-to-paid individual subscriptions with upsell to assays and biobanking; unit-priced research-grade assay sales with pay-as-you-go phlebotomy; annual tiered B2B SaaS subscriptions for longevity clinics; and enterprise subscriptions for research organizations plus white-label licensing fees. Distribution is predominantly direct-to-consumer through opencures.org and shop.opencures.org, with direct sales to mid-market clinics and research organizations and community-led referrals through longevity and biohacker networks. Named relationships include LongeCity (citizen science nonprofit), longevity clinics using the professional SaaS, research organizations running trials, and a coalition partnership within the Stanford-led THRIVE initiative backed by ARPA-H ($34.5M total program funding). The platform reports a 4.8/5 Trustpilot rating from over 2,000 reviews.

OpenCures firmographics

Firmographics
Name
OpenCures
Legal name
OpenOme Inc.
Website
https://opencures.org
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
OpenCures operates a cloud-based platform that aggregates biomarker, wearable, and self-tracking data for proactive individuals, longevity clinics, and research organizations, paired with an exclusive metabolomics assay (ProdromeScan), biobanking services, and a 501c(3) nonprofit partner.
Ownership category
akta.pro rank

OpenCures industry classification

Industry
Product category
Longevity Health Data Platform
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAIAL
Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAOAE
eConsent & Digital Identity for Trials
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAJAJ
Governance, Risk & Compliance (GRC) + HIPAA/HITRUST/ISO Readiness
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Cybersecurity, Identity & Privacy

Keywords

  • Health data platform
  • Biomarker tracking
  • Longevity research
  • Biobanking services
  • Clinical trial management

Where OpenCures is headquartered

Location

Headquarters

HQ city
Novato
HQ country
United States
HQ region
North America

Offices1 record

Markets served

OpenCures business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Platform SaaS Subscriptions: The for-benefit entity offers cloud-based software subscriptions to health professionals (longevity clinic client management) and research organizations (trial management). These are recurring revenue subscriptions with tiered feature access.
  2. ProdromeScan & Assay Services: OpenCures offers the ProdromeScan blood assay (metabolomics-based) and other blood panel tests directly to self-directed researchers and consumers. This is a one-time per-order revenue stream. Optional mobile phlebotomy service at ~$120 is available.
  3. Biobanking Services: Biospecimen storage service where participants can biobank remaining blood samples for future assay use, with ownership and access control retained by the individual. Revenue is generated per sample stored.
  4. White-label & Licensed Platform: OpenCures offers white-label versions of its platform to other longevity clinics, laboratories, and research organizations, embedding its technology into partner operations for a licensing fee.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProdromeScan assay — research-grade metabolomics blood test with results and interpretation workshop
Unit PricingPay-as-you-goMobile phlebotomy add-on for remote blood draws
FreemiumMonthlyPlatform for Individuals — personal health management dashboard with data integration and analytics
SubscriptionAnnualPlatform for Professionals — SaaS client management for longevity clinics

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

OpenCures product offering

Product offering

Core offering

OpenCures operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, and self-tracking inputs into a unified personal health management system. The company sells the research-grade ProdromeScan metabolomics blood assay, biobanking storage services, and dedicated SaaS modules for longevity clinics (client management) and research organizations (decentralized trial management). A hybrid for-benefit legal structure pairs the commercial entity (OpenOme Inc., DBA OpenCures) with a 501(c)(3) charity (OpenCures Access) to accelerate health technology development.

Product overview

OpenCures operates as a hybrid for-benefit enterprise offering a multi-product ecosystem centered on the OpenCures Platform (my.opencures.org), a web-based health data management system. The platform enables individuals to track biomarkers, integrate lab results and wearable data, and analyze health correlations. Complementary services include the ProdromeScan metabolomic assay (offered exclusively through OpenCures), biobanking for biospecimen storage, blood draw services (in-office and mobile phlebotomy), and dedicated modules for health professionals (client management) and researchers (trial management). An AI-assisted supplement planning feature personalizes wellness recommendations based on aggregated health data.

Differentiator

Problem solved

Functional benefit

Products and services

  • OpenCures Platform A web-based health management platform at my.opencures.org that enables individuals to track health metrics, integrate lab results and wearable data, analyze longitudinal correlations, and participate in self-directed research with automated biomarker calculations.
  • ProdromeScan A research-grade metabolomic blood test offered exclusively through OpenCures to self-directed researchers and consumers, providing comprehensive biomarker analysis with results automatically imported into the OpenCures Platform and accompanied by an interpretation workshop.
  • Biobanking Service Frozen biospecimen storage service for blood samples with user-controlled ownership and access, enabling future testing as new assays or biological age clocks become available.
  • Platform for Professionals A cloud-based client management system designed for longevity clinics, providing automated workflows, multi-source health data ingestion, automated reporting, and systematic holistic care delivery for client practices.
  • Trial Management Platform A research platform enabling decentralized trial management with media-rich study landing pages, protocol builders, guided participant flows, automated notifications, consent collection, questionnaires, multi-source data collection, and access to biobanking and assays.
  • Blood Draw Services Venous blood collection services available at the Novato, CA headquarters or via mobile phlebotomy (approximately $120 per session) nationwide in the US, required to obtain samples for the ProdromeScan assay and other tests.
  • White-label Platform Licensing White-label deployments of the OpenCures platform offered to partner longevity clinics, laboratories, and research organizations, embedding the technology into partner operations for a licensing fee.

Quantifiable outcome

  • Platform rated 4.8/5 on Trustpilot based on 2000+ reviews
  • +1 more outcomes

Companies that use OpenCures

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

OpenCures technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

OpenCures partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • WHOOPcoreStrategic or Co-development Partner · 4 March 2026WHOOP joined the $34.5 million ARPA-H-backed THRIVE initiative led by Stanford, with OpenCures as a named coalition partner. WHOOP will contribute continuous physiological data from its wearable devices to the PROSPR IC score model, integrating with OpenCures' data infrastructure and research participant network. The coalition aims to develop an FDA-grade Intrinsic Capacity score predicting major health outcomes up to 20 years in advance.
  • Stanford University (PROSPR)coreStrategic or Co-development Partner · 4 March 2026Stanford's PROSPR (Population-based Imaging and Informatics) team leads the THRIVE initiative, developing the PROSPR Intrinsic Capacity (IC) score model. OpenCures participates as a data and platform partner in the coalition, contributing participant engagement and multiomic data aggregation capabilities.
  • Buck Institute for Research on AgingcoreStrategic or Co-development Partner · 4 March 2026The Buck Institute for Research on Aging is a coalition partner in the Stanford-led THRIVE initiative. OpenCures participates alongside the Buck Institute to contribute to the development of the IC score and translate it into accessible at-home assessments.
  • Methuselah FoundationcoreStrategic or Co-development Partner · 4 March 2026Methuselah Foundation is a coalition partner in the ARPA-H-backed THRIVE initiative alongside OpenCures. The foundation has a long history supporting longevity science and is collaborating to accelerate translation of aging research into accessible health assessments.
  • YMCAminorStrategic or Co-development Partner · 4 March 2026YMCA is a coalition partner in the Stanford-led THRIVE initiative. As a community organization with broad reach, YMCA contributes to the accessibility and translation of the IC score into community settings.
  • Prodrome Sciences (ProdromeScan)coreTechnology or IntegrationOpenCures has an exclusive arrangement with ProdromeSciences to provide the ProdromeScan (research-grade metabolomics blood assay) to self-directed researchers. ProdromeSciences performs the analysis in San Diego, and OpenCures handles participant engagement, blood draw logistics, and result interpretation support.
  • LongeCitycoreStrategic or Co-development PartnerLongeCity collaborated with OpenCures to create a platform for the longevity community to share and analyze biomarker data. LongeCity's community of citizen scientists uses OpenCures' platform features for data management and research collaboration.
  • Open LongevityminorStrategic or Co-development PartnerOpen Longevity is listed as a partner organization on OpenCures' About page, collaborating within the integrated network of longevity clinics, research organizations, and biohacker communities.
  • AgelessRXminorStrategic or Co-development PartnerAgelessRX is listed as a partner organization, collaborating with OpenCures within the longevity ecosystem to accelerate access to health technologies.
  • Rejuve.iominorStrategic or Co-development PartnerRejuve.io is listed as a partner on OpenCures' About page, contributing to the integrated network approach to longevity research and health technology development.
  • OpenCures Access (501c3)coreStrategic or Co-development PartnerOpenCures partners with OpenCures Access, a 501c(3) nonprofit charity, to implement a multipronged strategy for accelerating health technology development. The nonprofit handles tasks that may not be directly profitable but are crucial for R&D, while the for-benefit entity handles commercially viable operations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

OpenCures competitors and assessment

Company assessment

Direct peers

  • Function Health: Direct-to-consumer blood-testing platform offering 100+ biomarker panels with longitudinal tracking and clinician review. Highly comparable to OpenCures' ProdromeScan + OpenCures Platform stack, targeting the same self-directed biohacker/health-conscious consumer.
  • InsideTracker: Biomarker analysis platform that ingests blood, wearable, and DNA data and produces personalized health recommendations. Closely matches OpenCures' biomarker analytics, personalized functional ranges, and AI-assisted supplement planning capabilities.
  • Viome: Consumer gut-microbiome and transcriptomic testing with AI-driven personalized nutrition recommendations. Same DTC-plus-data-platform-plus-AI-supplement model as OpenCures, and a direct competitor for self-directed longevity and wellness share of wallet.
  • Tally Health: Biological-age testing and longevity-focused supplement regimens sold direct-to-consumer with longitudinal self-tracking. Targets the same longevity-conscious biohacker segment and operates with a similar precision-prevention positioning.
  • Elysium Health: Longevity biotechnology company offering consumer-grade epigenetic biomarker products (e.g., Index) and supplements. Comparable in the consumer-longevity data + intervention offering that OpenCures is assembling through ProdromeScan and the platform.
  • Levels Health: Continuous metabolic monitoring (CGM) software with biomarker aggregation and AI-driven recommendations. Comparable consumer health-data SaaS playbook, sharing OpenCures' emphasis on longitudinal data, integrations, and AI-assisted intervention planning.

Broad incumbents

  • Thorne: Large supplement and health-testing brand with consumer lab-test offerings and practitioner channel. Overlaps with OpenCures' supplement-planning and biomarker analytics but operates at scale across multiple verticals rather than focusing on the longevity-research niche.
  • Human Longevity Inc. Premium longevity concierge-medicine and whole-genome/imaging diagnostic platform. Pursues a similar 'proactive longevity data' thesis but at a high-touch clinic + diagnostics model rather than OpenCures' DTC + community-driven model.
  • Fountain Life: Network of longevity/preventive-medicine clinics offering advanced diagnostics and AI-driven insights. Overlaps with OpenCures' longevity-clinic professional platform as both serve the same health-professional buyer with data-driven practice infrastructure.

Emerging players

  • Mito Health: Early-stage longevity-focused biomarker tracking and health-coaching platform. Targeting a similar self-directed health-optimization audience with a smaller subscription-based offering, representing a possible fast-moving entrant in OpenCures' core segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

OpenCures social profiles

Digital presence

OpenCures compliance and trust

Trust signal

Compliance2 records

OpenCures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OpenCures leadership team

Management profile

Number of profiles

Profiles1 record

OpenCures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OpenCures M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OpenCures

What does OpenCures do?

OpenCures operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, and self-tracking inputs into a unified personal health management system. The company sells the research-grade ProdromeScan metabolomics blood assay, biobanking storage services, and dedicated SaaS modules for longevity clinics (client management) and research organizations (decentralized trial management). A hybrid for-benefit legal structure pairs the commercial entity (OpenOme Inc., DBA OpenCures) with a 501(c)(3) charity (OpenCures Access) to accelerate health technology development.

Is OpenCures a public or private company?

OpenCures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was OpenCures founded?

OpenCures was founded in 2018. It employs 1 to 10 people.

Where is OpenCures based?

OpenCures is headquartered in Novato, United States, in the North America region.

How does OpenCures make money?

Four revenue lines are on record. Platform SaaS Subscriptions are the primary driver. The others are prodromeScan & Assay Services, biobanking Services and white-label & Licensed Platform.

Who are OpenCures's main competitors?

Direct peers on record are Function Health, InsideTracker, Viome, Tally Health, Elysium Health and Levels Health. Broad incumbents are Thorne, Human Longevity Inc. and Fountain Life. Mito Health is listed as an emerging player.

Does OpenCures have an API?

No public API is recorded for OpenCures.

What industry is OpenCures in?

OpenCures's product category is Longevity Health Data Platform. Its primary akta.pro industry code is HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement), with a secondary code of HLACAOAE, eConsent & Digital Identity for Trials. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales